-
公开(公告)号：US20100278767A1
公开(公告)日：2010-11-04
申请号：US12377395
申请日：2007-08-09
申请人： Horst Höffkes , Denise Fuhr , Wibke Gross , Georg Knübel , Doris Oberkobusch , Anja Reichert
发明人： Horst Höffkes , Denise Fuhr , Wibke Gross , Georg Knübel , Doris Oberkobusch , Anja Reichert
摘要： Agents for dyeing and/or lightening keratin fibers, in particular human hair, containing, relative to the weight thereof, 0.001 to 15 wt. % of at least one aldehyde of the formula (I): wherein X represents —CH(R2)—SO2—Y—R1, —CR3R4R5, or wherein Y represents —CH(CHO)— or —CH2— or a chemical bond, and wherein each of R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 independently represents —H or —CN or —F or —Cl or —Br or —I or —CHO or —NH2 or —NO2 or —CF3 or —CCl3 or —CF2CF3 or —CCl2CCl3 or an optionally substituted (C1-C6) alkyl group or a hydroxyalkyl group or a polyhydroxyalkyl group or an optionally substituted (C1-C6) alkylene group, and wherein the agent contains no oxidation dye precursors of developer and coupler type.
摘要翻译： 用于染色和/或减轻角蛋白纤维，特别是人发的剂，其含量相对于其重量为0.001至15wt。 ％的至少一种式（I）的醛：其中X表示-CH（R 2）-SO 2 -Y-R 1，-CR 3 R 4 R 5，或其中Y表示-CH（CHO） - 或-CH 2 - 或化学键， 并且其中R 1，R 2，R 3，R 4，R 5，R 6，R 7，R 8，R 9和R 10各自独立地表示-H或-CN或-F或-Cl或-Br或-I或-CHO或-NH 2或 -NO 2或-CF 3或-CCl 3或-CF 2 CF 3或-CCl 2 CCl 3或任选取代的（C 1 -C 6）烷基或羟烷基或多羟基烷基或任选取代的（C 1 -C 6）亚烷基，其中所述试剂包含 没有显影剂和耦合剂类型的氧化染料前体。
-
公开(公告)号：US20090176204A1
公开(公告)日：2009-07-09
申请号：US12381098
申请日：2009-03-06
CPC分类号： C12Q1/6886 , G01N33/574 , G01N33/57411 , G01N33/57484
摘要： The present invention relates to a method for improved diagnosis of dysplasias based on simultaneous detection of INK4a gene products and at least one marker for cell proliferation. Particularly the present invention provides a method for discriminating dysplastic cells over-expressing INK4a gene products from cells over-expressing INK4a gene products without being dysplastic by detection of a marker suitable for characterising the proliferation properties of the respective cell. The characterisation of the proliferation properties may comprise the detection of a marker or a set of markers characteristic for active cell proliferation and/or a marker or a set of markers characteristic for retarded or ceased cell proliferation. The method presented herein thus enables for a specific diagnosis of dysplasias in histological and cytological specimens.
摘要翻译： 本发明涉及一种基于同时检测INK4a基因产物和至少一种细胞增殖标志物来改善发育不良诊断的方法。 特别地，本发明提供了一种鉴别过表达INK4a基因产物的细胞过度表达INK4a基因产物的发育不良细胞的方法，通过检测适合于表征各细胞的增殖性质的标记物而不发育不良。 增殖特性的表征可以包括检测特征于活性细胞增殖的标志物或一组标志物和/或用于延迟或停止的细胞增殖的特征性标志物或一组标志物。 因此，本文提出的方法能够对组织学和细胞学标本中的发育不良进行特异性诊断。
-
3.发明授权公开(公告)号：US07932047B2
公开(公告)日：2011-04-26
申请号：US10569758
申请日：2004-08-20
申请人： Ruediger Ridder , Anja Reichert , Magnus Von Knebel Doeberitz , Matthias Herkert , Alexander Duwe , Rainer Hipfel , Peter Martin
发明人： Ruediger Ridder , Anja Reichert , Magnus Von Knebel Doeberitz , Matthias Herkert , Alexander Duwe , Rainer Hipfel , Peter Martin
IPC分类号： C12Q1/00 , G01N1/00 , G01N21/00 , G01N21/75 , G01N21/76 , G01N33/00 , G01N33/48 , G01N33/53 , G01N33/566 , G01N33/567 , G01N33/574 , C12P21/08
CPC分类号： G01N33/57484 , G01N33/57411 , Y10T436/25
摘要： The present invention relates to a method for the early diagnosis of neoplastic disorders such as cancers as well as their precursor stages, particularly cancers of the respiratory tract, the urinary system, the reproductive tract, cancer associated with HPV infection or cancer of the anogenital tract, from solubilized body samples. The invention is also directed to test kits usable for this purpose as well as in-vitro diagnostic devices. The development of the kits and in-vitro diagnostic devices for the above purpose is also one aspect of the present invention.
摘要翻译： 本发明涉及一种用于早期诊断肿瘤性疾病如癌症及其前体阶段的方法，特别是呼吸道癌症，泌尿系统，生殖道，与HPV感染有关的癌症或肛门生殖道癌症 ，来自溶解的身体样品。 本发明还涉及可用于该目的的测试试剂盒以及体外诊断装置。 用于上述目的的试剂盒和体外诊断装置的开发也是本发明的一个方面。
-
公开(公告)号：US20050272038A1
公开(公告)日：2005-12-08
申请号：US10522912
申请日：2003-07-17
CPC分类号： A61K38/1709 , A61K38/08 , A61K39/00 , C07K14/4703 , G01N33/57484
摘要： The present invention relates to a method for improved diagnosis of cervical lesions based on detection of gene products encoded by the INK4a gene locus. According to the present invention an improvement in diagnosis may be achieved by assessing the presence or absence or the level of overexpression of at least two different gene products encoded by the INK4a gene locus. In another aspect the present invention relates to peptides derived from cell cycle regulatory proteins, the expression of which is altered in association with tumors in individuals. These peptides according to the present invention may be used for detection and therapy of tumors. For detection purposes the peptides may for example be used to detect antibodies directed against said peptides. In therapeutic respect the peptides may be used for immunotherapy or vaccination approaches. In therapeutic and diagnostic respect the peptides may be used in combination with one or more peptides derived from tumor associated proteins.
摘要翻译： 本发明涉及一种基于由INK4a基因座编码的基因产物的检测来改善子宫颈病变诊断的方法。 根据本发明，可以通过评估由INK4a基因座编码的至少两种不同基因产物的过表达的存在或不存在或水平来实现诊断的改善。 在另一方面，本发明涉及衍生自细胞周期调节蛋白的肽，其表达与个体中的肿瘤相关联地改变。 根据本发明的这些肽可以用于肿瘤的检测和治疗。 为了检测目的，肽可以例如用于检测针对所述肽的抗体。 在治疗方面，肽可以用于免疫治疗或疫苗接种方法。 在治疗和诊断方面，肽可以与一种或多种衍生自肿瘤相关蛋白的肽组合使用。
-
公开(公告)号：US08236063B2
公开(公告)日：2012-08-07
申请号：US13291405
申请日：2011-11-08
申请人： Anja Reichert , Irmgard Bender , Mechtild Grunwald , Astrid Kleen
发明人： Anja Reichert , Irmgard Bender , Mechtild Grunwald , Astrid Kleen
IPC分类号： A61Q5/10
CPC分类号： A61Q5/10 , A61K8/442 , A61K8/463 , A61K8/86 , A61K2800/592 , A61K2800/596
摘要： Agent for oxidative coloring of keratinic fibers comprising a specific combination of non-ionic emulsifiers with a differing degree of ethoxylation and a specific combination of interfacially active substances comprising at least one anionic, at least one zwitterionic and at least one amphoteric surfactant. The agents provide good coloring characteristics while simultaneously protecting against damage to human hair. In particular the agents allow for colors with high color intensity and an improved gray coverage. The agents also provide significant advantages with regard to viscosity stability during storage and use and an improvement in shear sensitivity.
摘要翻译： 包含具有不同乙氧基化度的非离子乳化剂的特定组合和包含至少一种阴离子，至少一种两性离子和至少一种两性表面活性剂的界面活性物质的特定组合的角蛋白纤维的氧化着色剂。 这些试剂提供良好的着色特性，同时防止对人类头发的损伤。 特别地，这些试剂允许具有高颜色强度和改进的灰度覆盖的颜色。 这些试剂在储存和使用中的粘度稳定性和剪切敏感性的改善方面也具有显着的优点。
-
公开(公告)号：US20090181406A1
公开(公告)日：2009-07-16
申请号：US12400629
申请日：2009-03-09
申请人： Rudiger Ridder , Wolfgang Rudy , Matthias Herkert , Marcus Trunk-Gehmacher , Anja Reichert , Magnus Von Knebel Doeberitz
发明人： Rudiger Ridder , Wolfgang Rudy , Matthias Herkert , Marcus Trunk-Gehmacher , Anja Reichert , Magnus Von Knebel Doeberitz
CPC分类号： G01N33/57411 , G01N33/5076 , G01N33/5091 , G01N33/574 , G01N2333/82
摘要： This invention provides methods and kits for improved diagnosis of medically relevant conditions by solution based biochemical testing procedures performed in solutions of test samples. The invention provides a method to substitute the cell based morphological information contained within the cytological and/or histological data of the test sample by molecular information obtainable from the solution, wherein the original test sample is dissolved and thus enables for accurate and reproducible assessment of medically relevant diagnosis from dissolved test samples. The method according to the invention comprises the steps of determining the levels of one or more disease markers associated with the condition to be diagnosed, determining the level of one or more normalization markers suitable to substitute the information related to morphological aspects of the sample, comparing and/or combining the data of the disease and normalization markers, and assessing diagnosis of a medically relevant condition.
摘要翻译： 本发明提供用于通过在测试样品溶液中进行的基于溶液的生物化学测试程序来改善医学相关条件的诊断的方法和试剂盒。 本发明提供了一种通过从溶液获得的分子信息替代包含在测试样品的细胞学和/或组织学数据内的基于细胞的形态信息的方法，其中原始测试样品被溶解，因此能够准确和可重复地评估医学上的 溶解试样的相关诊断。 根据本发明的方法包括以下步骤：确定与待诊断的病症相关的一种或多种疾病标志物的水平，确定适合于替代与样品的形态学方面有关的信息的一种或多种标准化标记的水平，比较 和/或组合疾病和归一化标记的数据，以及评估医学相关病症的诊断。
-
公开(公告)号：US07306926B2
公开(公告)日：2007-12-11
申请号：US10650057
申请日：2003-08-26
IPC分类号： G01N33/574
CPC分类号： G01N33/57423 , G01N33/5076 , G01N33/5091 , G01N33/574 , G01N33/57407 , G01N33/57411 , G01N33/57488 , G01N2333/4739
摘要： The present invention relates to a method for the early diagnosis of carcinomas and their preliminary stages, which comprises determining the overexpression of a cell cycle regulatory protein in a solubilized body sample. The present invention is particularly directed to a method for detecting cervical carcinomas, cervical intraepithelial neoplasias, or cervical carcinomas in-situ from a solubilized cervical body sample of a human subject, by solubilizing the cervical body sample in a lysis buffer, and determining the overexpression of cyclin dependent kinase inhibitor p16 in the solubilized cervical sample. The invention also concerns a test kit usable for this purpose as well as an in-vitro diagnostic device.
摘要翻译： 本发明涉及一种早期诊断癌症的方法及其初步阶段，其包括确定溶解体样品中细胞周期调节蛋白的过表达。 本发明特别涉及通过将宫颈样品溶解在裂解缓冲液中，从人体受体的溶解的宫颈体样本中原位检测子宫颈癌，子宫颈上皮内瘤变或子宫颈癌的方法，并且确定过表达 的细胞周期蛋白依赖性激酶抑制剂p16在溶解的子宫颈样品中。 本发明还涉及可用于该目的的测试试剂盒以及体外诊断装置。
-
公开(公告)号：US08367353B2
公开(公告)日：2013-02-05
申请号：US12381098
申请日：2009-03-06
IPC分类号： G01N33/574
CPC分类号： C12Q1/6886 , G01N33/574 , G01N33/57411 , G01N33/57484
摘要： The present invention relates to a method for improved diagnosis of dysplasias based on simultaneous detection of INK4a gene products and at least one marker for cell proliferation. Particularly the present invention provides a method for discriminating dysplastic cells over-expressing INK4a gene products from cells over-expressing INK4a gene products without being dysplastic by detection of a marker suitable for characterizing the proliferation properties of the respective cell. The characterization of the proliferation properties may comprise the detection of a marker or a set of markers characteristic for active cell proliferation and/or a marker or a set of markers characteristic for retarded or ceased cell proliferation. The method presented herein thus enables for a specific diagnosis of dysplasias in histological and cytological specimens.
摘要翻译： 本发明涉及一种基于同时检测INK4a基因产物和至少一种细胞增殖标志物来改善发育不良诊断的方法。 特别地，本发明提供了一种鉴别过表达INK4a基因产物的细胞过度表达INK4a基因产物的发育不良细胞的方法，通过检测适合于表征各细胞的增殖性质的标记物而不发育不良。 增殖特性的表征可以包括检测特征于活性细胞增殖的标志物或一组标志物和/或用于延迟或停止的细胞增殖的特征性标志物或一组标志物。 因此，本文提出的方法能够对组织学和细胞学标本中的发育不良进行特异性诊断。
-
公开(公告)号：US20110318293A1
公开(公告)日：2011-12-29
申请号：US13228538
申请日：2011-09-09
CPC分类号： A61Q5/10 , A61K8/86 , A61K8/988 , A61K2800/4324 , A61Q5/04
摘要： Agent for changing the color and/or permanently changing the shape of keratinic fibers, wherein the agent contains in a cosmetic carrier at least one color- and/or shape-changing component as well as an animal-based care agent, in particular royal jelly, in combination with a polyalkoxylated fatty substance. The agents are suitable for reducing hair damage which occurs in connection with oxidative hair treatment such as oxidative hair coloring, hair lightening and perming.
摘要翻译： 用于改变角质形成纤维的颜色和/或永久改变角质形成纤维形状的药剂，其中所述药剂在化妆品载体中含有至少一种颜色和/或形状变化组分以及基于动物的护理剂，特别是蜂王浆 ，与多烷氧基化脂肪物质组合。 这些试剂适用于减少与氧化头发处理有关的毛发损伤，例如氧化毛发着色，发发光和烫发。
-
公开(公告)号：US07517662B2
公开(公告)日：2009-04-14
申请号：US10633484
申请日：2003-07-31
申请人： Rüdiger Ridder , Wolfgang Rudy , Matthias Herkert , Marcus Trunk-Gehmacher , Anja Reichert , Magnus Von Knebel Doeberitz
发明人： Rüdiger Ridder , Wolfgang Rudy , Matthias Herkert , Marcus Trunk-Gehmacher , Anja Reichert , Magnus Von Knebel Doeberitz
IPC分类号： G01N33/574
CPC分类号： G01N33/57411 , G01N33/5076 , G01N33/5091 , G01N33/574 , G01N2333/82
摘要： This invention provides methods for improved diagnosis of medically relevant conditions by solution based biochemical testing procedures performed in solutions of test samples. The invention provides a method to substitute the cell based morphological information contained within the cytological and/or histological data of the test sample by molecular information obtainable from the solution, wherein the original test sample is dissolved and thus enables for accurate and reproducible assessment of medically relevant diagnosis from dissolved test samples. The method according to the invention comprises the steps of determining the levels of one or more disease markers associated with the condition to be diagnosed, determining the level of one or more normalization markers suitable to substitute the information related to morphological aspects of the sample, comparing and/or combining the data of the disease and normalization markers, and assessing diagnosis of a medically relevant condition.
摘要翻译： 本发明提供了通过在测试样品溶液中进行的基于溶液的生物化学测试程序来改进医学相关条件诊断的方法。 本发明提供了一种通过从溶液获得的分子信息替代包含在测试样品的细胞学和/或组织学数据内的基于细胞的形态信息的方法，其中原始测试样品被溶解，因此能够准确和可重复地评估医学上的 溶解试样的相关诊断。 根据本发明的方法包括以下步骤：确定与待诊断的病症相关的一种或多种疾病标志物的水平，确定适合于替代与样品的形态学方面有关的信息的一种或多种标准化标记的水平，比较 和/或组合疾病和归一化标记的数据，以及评估医学上相关的病症的诊断。
-
-
-
-
-
-
-
-
-
搜索结果
15 条记录 (耗时 0.034 秒)
